Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pra Health (PRAH)

Pra Health (PRAH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pra Health 4130 PARKLAKE AVENUE SUITE 400 RALEIGH NC 27612 USA

P: 919-786-8200 F: +40 241701073

Description:

PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 10,928,324
Shares Outstanding, K 64,795
Annual Sales, $ 3,183 M
Annual Net Income, $ 197,040 K
Last Quarter Sales, $ 933,780 K
Last Quarter Net Income, $ 56,940 K
60-Month Beta 1.33
% of Insider Shareholders 1.30%
% of Institutional Shareholders 94.64%
Float, K 63,953
% Float 98.70%

Growth:

1-Year Return 78.04%
3-Year Return 75.69%
5-Year Return 302.53%
5-Year Revenue Growth 97.25%
5-Year Earnings Growth 101.03%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.35 on 04/28/21
Next Earnings Date 08/05/21
Earnings Per Share ttm 4.34
EPS Growth vs. Prev Qtr -4.55%
EPS Growth vs. Prev Year 44.83%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PRAH Ratios

Ratio
Price/Earnings ttm 39.01
Price/Earnings forward 28.23
Price/Earnings to Growth N/A
Return-on-Equity % 20.49%
Return-on-Assets % 7.07%
Profit Margin % 6.19
Net Margin % N/A
Debt/Equity 0.78
Price/Sales 3.45
Price/Cash Flow 27.79
Price/Book 7.08
Book Value/Share 24.02
Interest Coverage 7.01
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar